《大行報告》花旗引述友邦(01299.HK)管理層指第二季內地業務面臨挑戰
花旗發表報告表示,引述友邦(01299.HK)管理層透露,今年第二季內地業務較首季更具挑戰,主因去年比較基數高、市場對危疾產品的早期需求和新產品教育過程等因素。不過管理層稱,注意到與新危疾產品相關的活動有所增加,集團仍以每年在內地新增一至兩個省級牌照為目標,並會通過提前招聘新的分行管理人員作準備。
該行補充,香港業務而言,雖然邊境關閉可能會減少不活躍的經紀人數,但友邦協助該等經紀轉向拓展本地市場。管理層亦指出,最近東盟市場封鎖措施帶來問題,但在電子化下,代理有更好的準備。該行予友邦「買入」評級,目標價為116元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.